Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMPH.L Regulatory News (MPH)

  • There is currently no data for MPH

re: Contracts

7 Apr 2005 07:00

Marchpole Holdings PLC07 April 2005 07 April 2005 Marchpole Holdings plc ("the Company") MARCHPOLE CONTINUES TO EXPAND CASTELBAJAC Marchpole Holdings plc, which designs, produces and sells high quality clothingand accessories for six world class brands (Yves Saint Laurent, Boateng,Jean-Charles de Castelbajac ('JCC'), Rossignol, Emanuel Ungaro and Ungaro), ispleased to announce that three significant contracts for their Jean Charles deCastelbajac ("JCC") business have been agreed. Extended Agreement with Itochu for Japan The Company is pleased to announce that its design agreement with Itochu hasbeen extended for a further six years from 2005 to 2011. Itochu manufacture, wholesale and retail Castelbajac collections for theJapanese market place with sales at wholesale prices for 2004 over €25 million.As part of this new agreement the design fee on these sales will be increasedfrom the current rate of 1.7% to 2.5% from October 2005. Sales for 2005 areexpected to reach €30 million. Castelbajac and Rossignol Launch New Collection Jean Charles de Castelbajac designed and launched his first Skiwear collectionfor the Autumn Winter 2002 season in collaboration with the world's number oneskiwear brand Rossignol. Over the course of the last two years sales haveincreased from €0.5 million to €3.2 million for Autumn Winter 2004 and sales forAutumn Winter 2005 are forecast to be €3.7 million. This is the fastest growingbusiness line within the Rossignol group. Following this success, Rossignol have asked Jean Charles to design and launch anew collection for the Summer. This new collection is aimed at the TrekkingOutdoor market. Launching in the Spring Summer 2006 season, the new agreement is for 5 years,with minimum guaranteed royalties over the period totalling €325,000. Castelbajac Glasses and Sunglasses The company has also signed an agreement with Codir SA to launch Castelbajaceyewear across Europe. Codir SA are the leader in market share with more than2700 retail outlets and sales of over €700 million. The contract is for 3 years, launching in Spring Summer 2005 with minimumguaranteed royalties for the period of €230,000. Commenting today, Chief Executive Greg Tufnell said : "Marchpole acquired the Castelbajac business in 2004 with the aim of creating astrong worldwide brand under its ownership. These new contracts, and thesignificant marketing contribution from the licensees, clearly demonstrate ourability to transform and grow this brand. We are successfully increasing ourpresence across a wide assortment of product categories and establishing thebrand in both Asia and Europe" For further information contact: Marchpole Greg Tufnell - Chief Executive 020 7908 7700 Michael Morris - Executive Director Shore Capital Alex Borrelli 020 7408 4090 Buchanan Tim Thompson / Nicola Cronk 020 7466 5000 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
10th Sep 20191:00 pmRNSNotice of Results
6th Sep 20197:00 amRNSBlock listing Interim Review
4th Sep 20191:00 pmRNSMereo announces phase 2b data at ASBMR Meeting
16th Aug 20191:51 pmRNSDirector/PDMR Shareholding
15th Aug 20194:59 pmRNSPDMR Shareholding
12th Aug 20194:41 pmRNSSecond Price Monitoring Extn
12th Aug 20194:35 pmRNSPrice Monitoring Extension
9th Aug 20194:35 pmRNSPrice Monitoring Extension
31st Jul 201912:51 pmRNSDirector Declaration
25th Jul 20194:56 pmRNSPDMR Shareholding
24th Jul 201910:08 amRNSDirector/PDMR Shareholding
19th Jul 20191:21 pmRNSDirector/PDMR Shareholding
16th Jul 20191:00 pmRNSAppointment of Richard Francis
15th Jul 20191:00 pmRNSSuccessful Type B Meeting with U.S. FDA
8th Jul 20193:54 pmRNSHolding(s) in Company
3rd Jul 20194:41 pmRNSSecond Price Monitoring Extn
3rd Jul 20194:35 pmRNSPrice Monitoring Extension
27th Jun 20193:33 pmRNSHolding(s) in Company
26th Jun 20194:36 pmRNSHolding(s) in Company
21st Jun 20191:00 pmRNSConversion of loan note and issue of equity
20th Jun 20197:00 amRNSResult of AGM
13th Jun 20191:00 pmRNSUpdate on Etigilimab (TIGIT) Partnership
30th May 20197:00 amRNSPositive early 6 month data
23rd May 20194:11 pmRNSDirector/PDMR Shareholding
22nd May 20199:45 amRNSPDMR Shareholding
21st May 20193:08 pmRNSDirector/PDMR Shareholding
20th May 20197:00 amRNSNotice of AGM
8th May 20191:53 pmRNSDirector/PDMR Shareholding
7th May 20197:00 amRNSIssue of Warrants
7th May 20197:00 amRNSRe-release: Intention to Purchase Shares
3rd May 20195:00 pmRNSIntention to Purchase Shares by Trustee of EBT
3rd May 20192:02 pmRNSDirector/PDMR Shareholding
1st May 20193:47 pmRNSDirector/PDMR Shareholding
30th Apr 20193:15 pmRNSDirector/PDMR Shareholding
30th Apr 20197:00 amRNSDirector/PDMR Shareholding
30th Apr 20197:00 amRNSPublication of Annual Report and Accounts
29th Apr 20197:00 amRNSPrelims Results for year ended December 31 2018
26th Apr 20193:01 pmRNSDirector/PDMR Shareholding
25th Apr 20193:36 pmRNSHolding(s) in Company
25th Apr 20193:29 pmRNSHolding(s) in Company
24th Apr 20192:30 pmRNSAdmission to Trading
23rd Apr 20192:25 pmRNSCompletion of Merger
18th Apr 20197:00 amRNSMerger Update
15th Apr 20197:00 amRNSSuccessful end of Phase 2 Meeting with FDA
21st Mar 20197:00 amRNSPublication of Form F-4
15th Mar 201911:45 amRNSUpdate on Proposed Combination of Mereo & OncoMed
13th Mar 201911:00 amRNSMereo CEO appointed NED of Elanco Animal Health
6th Mar 20197:00 amRNSBlock Listing Interim Review
5th Mar 20191:32 pmRNSMereo to present at Cowen and Company Conference
22nd Feb 20191:50 pmRNSUpdate on Proposed Transaction with OncoMed

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.